quinoxalines has been researched along with sb 225002 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Araújo, SB; Calixto, JB; Costa, R; Fernandes, ES; Manjavachi, MN; Passos, GF; Pontes, JP; Trevisan, G | 1 |
1 other study(ies) available for quinoxalines and sb 225002
Article | Year |
---|---|
Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice.
Topics: Animals; Antineoplastic Agents, Phytogenic; Chemokine CXCL1; Ganglia, Spinal; Mice; Neurons; Paclitaxel; Peripheral Nervous System Diseases; Phenylurea Compounds; Phosphatidylinositol 3-Kinases; Quinoxalines; Receptors, Interleukin-8B; Signal Transduction; Spinal Cord; Thiazolidinediones | 2019 |